Guiding abx prescription by matching the infecting bug with the correct drug by combining #moleculardiagnostics with epidemiological surveillance and big-data.
ID Genomics, SPC, is offering rapid sequencing of key genomic regions of SARS-CoV-2 able to differentiate thousands of currently circulating variants, including multiple sub-variants of the Omicron, Delta and other variants.
November 18-24, 2021 is U.S. Antibiotic Awareness Week.
ID Genomics is committed to fight antibiotic resistance by developing precision diagnostic tests to guide antibiotic choices
Please visit our website to know more
idgenomics.com/our-products/
ID Genomics, SPC, is in the process of launching a next-day cost-effective service to identify all SARS-CoV-2 variants currently being monitored– Delta, Mu, Gamma, Epsilon, Iota, etc - and hundreds of their structural and nonstructural subvariants.
We are excited to be on the news!!
"Alongside Seattle-based ID Genomics, which Sokurenko founded, the professor’s laboratory is leading the creation and future implementation of a new method to “fingerprint” all currently known variants."
newsroom.uw.edu/resource/new…
The perfect storm - COVID-19 underscores the need to be prepared for the next pandemic, and the pressing need for vaccines, diagnostics, antibiotics and other therapeutics to address bacterial infections and AMR. pharmatimes.com/magazine/202…
Today = 1 week of our #pathology resident and fellow-led volunteer COVID Collection Team doing their thing!! I’m so proud of these guys stepping up big time - so lucky to have such wonderful trainees here @LACUSCMedCenter 🙏😄@CostalesPathMD
IDG Team is proud to announce the completion of the first Pre-Submission meeting with the FDA for the CLoNeT E. coli Assay for Urinary Tract Infections (UTIs).
prnewswire.com/news-releases…
Simple infections become more resistant to antibiotics. IDGenomics develops a rapid diagnostic test to detect UTI pathogen, predict its antibiotic susceptibility in under an hour for a more precise antibiotic prescription.
wbur.org/hereandnow/2019/07/…